There are a few things to consider when using an iCARE Malaria P. falciparum Rapid Test Kit, from how accurate it is.
Molecular Detection of Low-density P. falciparum Infections
A novel malaria diagnostic test that combines ddPCR and qPCR has been developed by the iCARE company. This rapid test kit is a highly sensitive and specific method for the detection of parasite DNA in human blood samples. The kit is designed to identify the presence of P. falciparum parasite DNA in a range of samples.
The new test is more sensitive than previous rapid malaria diagnostic kits for detecting parasite DNA. It also allows for high-throughput detection of P. falciparum DNA in DBS. However, the method requires a dedicated PCR laboratory. In addition, it provides more accurate prevalence data. A full data set can be requested from M. Hetzel and colleagues.
The assay is highly sensitive and specific and detects tRNA positivity and hrp2 and hrp3 deletions. It is also sensitive enough to detect mixed infections between parasites with wild-type and hrp2 deletion. In a recent study, the assay was validated with samples from six countries. The results showed good performance. The study found that the assay was accurate across a wide range of parasite densities. The data showed that the RDT performed well. However, some of the field samples required repeated testing due to poor separation between the negative and positive droplets.
Accuracy of Rapid Diagnostic Tests for Malaria
Rapid diagnostic tests for malaria have a number of advantages. The tests detect malaria antigens in a small amount of blood without the use of a microscope and can provide a positive or negative result within 15 minutes. The tests can be used in endemic areas where microscopy is not a viable option.
Several tests have been developed to measure the accuracy of diagnosis of malaria. These include the Gazelle test, malaria specific polymerase chain reaction (PCR), and RDT. Each test has a range of sensitivity and specificity, which vary based on the type of infection and the goals of malaria control in a given region.
Accurate malaria diagnosis is crucial to improving case management and reducing associated morbidity and mortality. Accurate diagnosis is also important for epidemiological screening, informing malaria control strategies, and testing antimalarial drugs.
iCARE Malaria P. falciparum Rapid Test Kit
The cost of malaria rapid diagnostic tests (RDTs) is lower than the price of the drug malarial artemisinin. These tests can detect malaria parasites in peripheral blood. They use a finger or heel prick and provide results within 20 minutes. RDTs require no specialist services or infrastructure and are suitable for use in remote areas.
Malaria research is ongoing to improve the effectiveness of malaria diagnostic tools. Researchers have developed a real-time malaria diagnostic test called RealAmp. Researchers are now testing this real-time malaria diagnostic kit to determine its efficacy. They also hope the rapid test will improve the rate of detection of malaria in low-income areas.
It is recommended for use by healthcare workers in remote areas where malaria is prevalent. However, it should not be used for follow-up of malaria patients. Moreover, the results of RDTs should be interpreted cautiously. In case of doubt, the results of the test should be verified by a BFT. Furthermore, uncontrolled migratory flows might introduce new variants of Plasmodium and affect the test’s efficiency.